Authors' recommendations: The prevalence of VTE, DVT, and PE within 90 days after hip arthroplasty was 853 (3.8%), 597 (2.7%), and 327 (1.5%), respectively. The prevalence of VTE, DVT, and PE within 90 days after knee arthroplasty was 1,990 (3.8%), 1,699 (3.2%) and 355 (0.7%), respectively. A previous history of VTE takes a central role in the prevalence of VTE. The prevalence of VTE after hip arthroplasty was 5.7 times higher in patients with a previous history of VTE than in patients with no history of VTE. In terms of the types of arthroplasty, there was a significant difference in revision elective arthroplasty; the prevalence of VTE was 16 times higher in patients with a previous history of VTE who received revision elective arthroplasty. Likewise, the prevalence of VTE after knee arthroplasty was five times higher in patients with a previous history of VTE than in patients with no history of VTE. There was no significant difference among the types of arthroplasty. It is obvious that VTE occurs more commonly in groups with a previous history of VTE in both types of arthroplasty. However, it was not statistically significant in the groups with a previous history of VTE even with the higher prevalence rate. Also, it is not statistically significant in some drug groups either, while the prevalence was higher.

Project Status: Completed

Year Published: 2012

URL for published report: http://www.neca.re.kr/center/researcher/report_view.jsp?boardNo=GA&seq=66&q=626f6172644e6f3d4741

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: South Korea

Organisation Name: National Evidence-based healthcare Collaborating Agency

Contact Address: National Evidence-based Healthcare Collaborating Agency (NECA), 3~5F Health and Welfare Social Administration B/D, 400 Neungdong-ro, Gwangjin-gu, Seoul, Korea.

Contact Name: int@neca.re.kr

Contact Email: int@neca.re.kr

Copyright: National Evidence-based Healthcare Collaborating Agency (NECA)